产品
编 号：F060112
分子式：C23H29NO5
分子量：399.48
分子式：C23H29NO5
分子量：399.48
产品类型
规格
价格
是否有货
10mM*1mL in DMSO
询价
询价
1mg
询价
询价
5mg
询价
询价
10mg
询价
询价
25mg
询价
询价
结构图
CAS No: 1185241-83-1
产品详情
生物活性：
Tesmilifene fumarate (DPPE fumarate), an H1C receptor antagonist, potentiates a wide range of cytotoxics and even to offer some protection of normal cells.
体内研究：
Tesmilifene (DPPE, 20 mg/kg (s.c.) and 20 μg (icv in 5 μL)) potentiated seizures induced by both convulsants.Animal Model:Male BKTO mice (25-45 g).
Dosage:20 mg/kg (s.c.) and 20 μg (icv in 5 μL).
Administration:S.C. and icv.
Result:Potentiated seizures induced by both convulsants.
体外研究：
Tesmilifene may modulate the effects of 12(S)HETE in cancer cells, and indirectly, influence the susceptibility of cellular DNA to chemotherapy.
Tesmilifene fumarate (DPPE fumarate), an H1C receptor antagonist, potentiates a wide range of cytotoxics and even to offer some protection of normal cells.
体内研究：
Tesmilifene (DPPE, 20 mg/kg (s.c.) and 20 μg (icv in 5 μL)) potentiated seizures induced by both convulsants.Animal Model:Male BKTO mice (25-45 g).
Dosage:20 mg/kg (s.c.) and 20 μg (icv in 5 μL).
Administration:S.C. and icv.
Result:Potentiated seizures induced by both convulsants.
体外研究：
Tesmilifene may modulate the effects of 12(S)HETE in cancer cells, and indirectly, influence the susceptibility of cellular DNA to chemotherapy.
产品资料
Copyright©2015-2024 沪ICP备2022026524号-1
沪公网安备